Skip to content

Comparing the effectiveness and safety of intraoperative intravenous infusion of esketamine or sufentanil for sedation, analgesia and anesthesia in patients undergoing large-area liposuction: a randomized clinical trial

Comparing the effectiveness and safety of intraoperative intravenous infusion of esketamine or sufentanil for sedation, analgesia and anesthesia in patients undergoing large-area liposuction: a randomized clinical trial

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075123
Enrollment
Unknown
Registered
2023-08-25
Start date
2023-06-30
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation Anesthesia Surgery Patients

Interventions

Esketamine group:Esketamine

Sponsors

Plastic Surgery Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years, gender is not limited; 2.The ASA I ~ II grade; 3.Sign an informed consent form with the patient before surgery.

Exclusion criteria

Exclusion criteria: 1. Abnormal liver and kidney function before operation; 2. Patients with acute or chronic pain before surgery and had taken analgesics within 48 hours; 3. Have organic congenital heart disease, arrhythmia or hypertension; 4. Severe lung disease in the past month; 5. Preoperative language communication and cognitive impairment, sleep problems; 6. Previous history of severe mental or neurological diseases, drug or psychotropic drug abuse, long-term use of steroids and hormone drugs; 7. Recent history of major surgery, severe visual and hearing impairment.

Design outcomes

Primary

MeasureTime frame
Patient's and operator's satisfaction score;

Secondary

MeasureTime frame
Intraoperative vital signs;Perioperative adverse reactions;Intraoperative opioid consumption;Athens insomnia Scale scores after surgery;Postoperative anxiety and depression scores;

Countries

China

Contacts

Public ContactWei Linxin

Plastic Surgery Hospital, Chinese Academy of Medical Sciences

weilx3934@sina.com+86 136 2115 9500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026